CN1162399C - 氨基酸碘络合物 - Google Patents
氨基酸碘络合物 Download PDFInfo
- Publication number
- CN1162399C CN1162399C CNB011146664A CN01114666A CN1162399C CN 1162399 C CN1162399 C CN 1162399C CN B011146664 A CNB011146664 A CN B011146664A CN 01114666 A CN01114666 A CN 01114666A CN 1162399 C CN1162399 C CN 1162399C
- Authority
- CN
- China
- Prior art keywords
- amino acid
- iodine
- complex
- iodine complex
- add
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000011630 iodine Substances 0.000 title claims abstract description 51
- 229910052740 iodine Inorganic materials 0.000 title claims abstract description 51
- 150000001413 amino acids Chemical class 0.000 title claims abstract description 38
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 title abstract description 39
- 239000008139 complexing agent Substances 0.000 claims abstract description 13
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims abstract description 12
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229940024606 amino acid Drugs 0.000 claims description 34
- 235000001014 amino acid Nutrition 0.000 claims description 34
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 16
- 239000000126 substance Substances 0.000 claims description 13
- 229930182817 methionine Natural products 0.000 claims description 10
- 239000004471 Glycine Substances 0.000 claims description 7
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 6
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims description 5
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 5
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 5
- XUYPXLNMDZIRQH-LURJTMIESA-N N-acetyl-L-methionine Chemical compound CSCC[C@@H](C(O)=O)NC(C)=O XUYPXLNMDZIRQH-LURJTMIESA-N 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 5
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 4
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 3
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 3
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 3
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 3
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 3
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 3
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 3
- 239000004475 Arginine Substances 0.000 claims description 2
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 claims description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 2
- 239000004473 Threonine Substances 0.000 claims description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 2
- 239000006035 Tryptophane Substances 0.000 claims description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 2
- 235000003704 aspartic acid Nutrition 0.000 claims description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 2
- 229960002989 glutamic acid Drugs 0.000 claims description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 2
- 229960000310 isoleucine Drugs 0.000 claims description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 2
- 229960004799 tryptophan Drugs 0.000 claims description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 5
- 235000016709 nutrition Nutrition 0.000 abstract description 4
- 241000894006 Bacteria Species 0.000 abstract description 3
- 241000700605 Viruses Species 0.000 abstract description 3
- 239000000645 desinfectant Substances 0.000 abstract description 2
- 230000002147 killing effect Effects 0.000 abstract description 2
- 235000015097 nutrients Nutrition 0.000 abstract description 2
- 239000003674 animal food additive Substances 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 239000003899 bactericide agent Substances 0.000 abstract 1
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 239000002778 food additive Substances 0.000 abstract 1
- 235000013373 food additive Nutrition 0.000 abstract 1
- 238000003756 stirring Methods 0.000 description 21
- 238000002360 preparation method Methods 0.000 description 12
- 239000012141 concentrate Substances 0.000 description 9
- 238000001035 drying Methods 0.000 description 9
- 239000000706 filtrate Substances 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 238000010792 warming Methods 0.000 description 9
- 241000238557 Decapoda Species 0.000 description 5
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical compound Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 description 4
- 229960005337 lysine hydrochloride Drugs 0.000 description 4
- -1 tri-arginine iodine Chemical compound 0.000 description 4
- HOMROMWVNDUGRI-RVZXSAGBSA-N (2s)-2-aminopentanedioic acid;(2s)-2,6-diaminohexanoic acid Chemical compound NCCCC[C@H](N)C(O)=O.OC(=O)[C@@H](N)CCC(O)=O HOMROMWVNDUGRI-RVZXSAGBSA-N 0.000 description 3
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- YKKOLVVNHPLQKF-UHFFFAOYSA-N 2-aminoacetic acid;iodine Chemical compound [I].NCC(O)=O YKKOLVVNHPLQKF-UHFFFAOYSA-N 0.000 description 2
- 102000004452 Arginase Human genes 0.000 description 2
- 108700024123 Arginases Proteins 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000282414 Homo sapiens Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000607598 Vibrio Species 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 101150024183 tigar gene Proteins 0.000 description 2
- CPYVQXAASIFAMD-KNIFDHDWSA-N (2s)-2-aminobutanedioic acid;(2s)-2,6-diaminohexanoic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O.NCCCC[C@H](N)C(O)=O CPYVQXAASIFAMD-KNIFDHDWSA-N 0.000 description 1
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 1
- ONFOSYPQQXJWGS-UHFFFAOYSA-N 2-hydroxy-4-(methylthio)butanoic acid Chemical compound CSCCC(O)C(O)=O ONFOSYPQQXJWGS-UHFFFAOYSA-N 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 241000530454 Litopenaeus schmitti Species 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- GTXDNVCCXSRTGT-DFWYDOINSA-N N[C@@H](CCC(=O)O)C(=O)O.[I] Chemical compound N[C@@H](CCC(=O)O)C(=O)O.[I] GTXDNVCCXSRTGT-DFWYDOINSA-N 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- IEEUKPDEGHCHDZ-UHFFFAOYSA-N [H]N[I]C(=O)O[H] Chemical compound [H]N[I]C(=O)O[H] IEEUKPDEGHCHDZ-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 150000001412 amines Chemical group 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 229910052755 nonmetal Inorganic materials 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000003206 sterilizing agent Substances 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 241000701447 unidentified baculovirus Species 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A01N59/12—Iodine, e.g. iodophors; Compounds thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/30—Oligoelements
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Husbandry (AREA)
- Food Science & Technology (AREA)
- Inorganic Chemistry (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Health & Medical Sciences (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Environmental Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
一种用于制备饲料和食品添加剂以及用于制备消毒剂、杀菌剂和药物的氨基酸碘络合物,其配位中心是碘分子,络合剂是氨基酸;由于氨基酸是营养剂,它的引入既增加了络合物的营养功能,又更有利于保护环境,并具有好的稳定性,提高了碘对细菌和病毒的消杀能力。
Description
本发明涉及化学领域,特别是用于制备饲料和食品添加剂,以及用于制备消毒剂、杀菌剂和药物的氨基酸碘络合物。
碘是必需的营养素之一,碘酊作为消毒杀菌剂已有长久的历史。碘是治疗甲状腺肿的特效药物。由于碘分子易于升华,不稳定是其最大的缺点。为了制备稳定性碘,德国专利DE-2941387和DE-3060935提供了聚乙烯吡咯烷酮碘(简称PVP-碘),是一种络合物,其中PVP是络合剂,PVP-碘的稳定性比较好,但络合剂PVP并不是动物体所需要的。用季胺盐制成的络合碘也存在同样的问题。
本发明的目的在于针对现有技术的不足,提供一种能使碘分子稳定,络合剂又可作为营养剂的氨基酸碘络合物。
依据络合原理,络合剂的选择是关键。碘是非金属,同时又具金属的特性。氨基酸可作络合剂,又是营养剂,其络合能力适中,有利于通过生物的新陈代谢提高消杀能力。因此使氨基酸与碘发生络合,就可形成稳定的活性氨基酸碘络合物。
本发明氨基酸碘络合物,其配位中心是碘分子,络合剂是氨基酸,其化学结构式为:
其中R1、R2代表氨基酸中的侧链基,m,n分别代表组成络合物的氨基酸分子的数目。
R1、R2可以相同也可以不同,R1=R2时络合剂由同种氨基酸构成,R1、R2不同时络合剂由不同氨基酸构成。当R1或R2=H时上式中的氨基酸为甘氨酸(Gly),当R1或R2=CH3时上式的氨基酸为丙氨酸(Ala),其余类推。
作为络合剂的氨基酸,可以是同种或不同种的简单氨基酸,例如丙氨酸(Ala)、精氨酸(Arg)、天冬酰胺(Asn)、天冬氨酸(Asp)、胱氨酸(Cys)、谷氨酰胺(Gln)、谷氨酸(Glu)、甘氨酸(Gly)、组氨酸(His)、异亮氨酸(Ile)、亮氨酸(Leu)、赖氨酸(Lys)、甲硫氨酸(蛋氨酸,Met)、苯丙氨酸(Phe)、脯氨酸(Pro)、丝氨酸(Ser)、苏氨酸(Thr)、色氨酸(Trp)、酪氨酸(Tyr)、缬氨酸(Val)。
所述络合剂除了可以是氨基酸外,还可以是上述简单氨基酸的衍生物,例如乙酰蛋氨酸、蛋氨酸羟基类似物;或是简单氨基酸形成的简单肽,例如赖氨酸天冬氨酸盐、赖氨酸谷氨酸盐;还可以是动物蛋白和/或植物蛋白经水解所产生的复合氨基酸等。
根据氨基酸不同和使用要求的不同,氨基酸对碘分子的克分子比不同,一般在1-20比较适宜,最佳范围是1-5。
本发明与现有技术相比具有如下优点:
1、由于氨基酸是营养剂,它的引入既增加了络合物的营养功能,又更有利于保护环境;
2、由于本发明的氨基酸碘络合物是一种以碘分子为配位中心的络合物,因此具有较好的稳定性。
3、氨基酸同碘有协合作用,因而提高了碘对细菌和病毒的消杀能力,灭菌效果提高了数倍。
4、使用安全性显著超过了PVP-碘。
5、氨基酸碘络合物具有良好的溶解性能,它的制剂易于溶解,降低了成本和毒性。
6、提升和扩大了碘的用途。在养殖业、种植业、医疗卫生、营养药物等方面都将广为应用。它将成为病毒和细菌的强力杀手。护卫人类的健康和绿色产业。
本发明可以按照下列实施例进行实施。
实施例一 甘氨酸碘的制备。
在带有加热和磁性搅拌的250ml圆底烧瓶中(下同),加入水100ml,搅拌升温至55℃,加入甘氨酸20g,待溶解完全后,逐步加入碘25g,搅拌150min,过滤,滤液浓缩干燥,所得产物经化验,含碘22.1g,含甘氨酸19.0g。
实施例二 赖氨酸碘的制备。
设备同实施例一。向圆底烧瓶中,加入水85ml,搅拌升温至75℃,加入赖氨酸盐酸盐24g,待溶解完全后,逐步加入碘19g,搅拌130min,过滤,滤液浓缩干燥,所得产物经化验,含碘16.1g,含赖氨酸盐酸盐23.5g。
实施例三 精氨酸碘的制备
设备同实施例一。向圆底烧瓶中,加入水150ml,搅拌升温至80℃,加入精氨酸26g,待溶解完全后,逐步加入碘4.4g,搅拌110min,冷却,静置180min,过滤,分离,滤液浓缩干燥,所得产物经化验,含碘2.3g,含精氨酸23.7g。
实施例四 天冬酰胺碘的制备。
设备同实施例一。向圆底烧瓶中,加入水105ml,搅拌升温至65℃,加入天冬酰胺6g,逐步加入碘1.0g,搅拌110min,过滤,滤液浓缩干燥,所得产物经化验,含碘0.94g,含天冬酰胺2.40g。
实施例五 蛋氨酸碘的制备。
设备同实施例一。向圆底烧瓶中,加入乙醇120ml,搅拌升温至55℃,加入碘3.5g,待溶解完全后,逐步加入蛋氨酸15g,搅拌180min,过滤,滤液浓缩干燥,所得产物经化验,含碘3.01g,含蛋氨酸7.94g。
实施例六 酪氨酸碘的制备。
设备同实施例一。向圆底烧瓶中,加入水200ml,搅拌升温至70℃,加入酪氨酸500mg,搅拌下逐步加入碘1.0g,搅拌200min,静置,过滤,滤液浓缩干燥,所得产物经化验,含碘0.10g,含酪氨酸0.48g。
实施例七 甘氨酸赖氨酸碘的制备。
设备同实施例一。向圆底烧瓶中,加入水150ml,搅拌升温至68℃,加入甘氨酸3.4g,赖氨酸盐酸盐8.0g,待溶解完全后,逐步加入碘7.2g,搅拌128min,过滤,滤液浓缩干燥,所得产物甘氨酸赖氨酸碘,经化验,含碘5.5g,含甘氨酸3.3g,赖氨酸盐酸盐7.8g。
实施例八 复合氨基酸碘的制备。
设备同实施例一。明胶经盐酸水解获得复合氨基酸,氮含量5.87%。向圆底烧瓶中,加入水解氨基酸85g,搅拌升温至72℃,加入碘6.6g,搅拌192min,过滤,滤液浓缩干燥,所得产物经化验,含碘4.5g,含氮5.7%。
实施例九 赖氨酸谷氨酸碘的制备。
设备同实施例一。向圆底烧瓶中,加入水110ml,搅拌升温至65℃,加入赖氨酸谷氨酸盐25g,待溶解完全后,逐步加入碘9.7g,搅拌220min,过滤,滤液浓缩干燥,所得产物经化验,含碘8.5g,含赖氨酸谷氨酸盐23.2g。
其它简单氨基酸或复合氨基酸的碘络合物,均可用类似的方法制备。
本发明的应用。
应用本发明制成含活性碘5%的甘氨酸碘络合物浓缩液。在1.6公顷的虾塘中,水深1.1M,放养白对虾60万尾。夜晚观察,发现水体发光,查明是发光弧菌。次日晚用含碘0.01ppm的本发明,进行水体消毒。40分钟后,发光现象已经消失。氨基酸碘对发光弧菌有很好的杀灭作用。
应用本发明制成含活性碘4%的复合氨基酸碘络合物浓缩液。在1.1公顷的虾塘中,育有斑节对虾42万尾,体长已达8.5cm。100尾虾中有一尾出现白斑。经查是杆状病毒病。按每公斤饲料拌和4g与10g鱼油混合后的本发明,连续投喂4天,白斑病获得了控制。此后每天投喂一次拌饵,斑节对虾长至12cm,成活率80%。
本发明对西红柿的早晚疫病防治,餐具、医疗器械的消毒等均有良好的效果。本发明开拓了人类健康事业的新途径。
Claims (5)
1、一种氨基酸碘络合物,其特征在于其配位中心是碘分子,络合剂是氨基酸,具有如下化学结构:
其中R1、R2代表氨基酸中的侧链基,m,n分别代表组成络合物的氨基酸分子的数目,R1、R2可以相同也可以不同。
2、根据权利要求1所述的氨基酸碘络合物,其特征在于作为络合剂的氨基酸,可以是同种或不同种的简单氨基酸。
3、根据权利要求2所述的氨基酸碘络合物,其特征在于简单氨基酸是丙氨酸、精氨酸、天冬酰胺、天冬氨酸、胱氨酸、谷氨酰胺、谷氨酸、甘氨酸、组氨酸、异亮氨酸、亮氨酸、赖氨酸、甲硫氨酸、苯丙氨酸、脯氨酸、丝氨酸、苏氨酸、色氨酸、酪氨酸、缬氨酸。
4、根据权利要求1所述的氨基酸碘络合物,其特征在于氨基酸对碘分子的克分子比是1-20。
5、根据权利要求4所述的氨基酸碘络合物,其特征在于氨基酸对碘分子的克分子比是1-5。
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011146664A CN1162399C (zh) | 2001-04-28 | 2001-04-28 | 氨基酸碘络合物 |
CNB018116701A CN1207271C (zh) | 2001-04-28 | 2001-10-19 | 氨基酸碘络合物 |
PCT/CN2001/001490 WO2002088068A1 (fr) | 2001-04-28 | 2001-10-19 | Complexe d'acide amine-iodine |
US10/312,521 US7195772B2 (en) | 2001-04-28 | 2001-10-19 | Amino-acid iodine complex |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011146664A CN1162399C (zh) | 2001-04-28 | 2001-04-28 | 氨基酸碘络合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1318539A CN1318539A (zh) | 2001-10-24 |
CN1162399C true CN1162399C (zh) | 2004-08-18 |
Family
ID=4661294
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB011146664A Expired - Lifetime CN1162399C (zh) | 2001-04-28 | 2001-04-28 | 氨基酸碘络合物 |
CNB018116701A Expired - Lifetime CN1207271C (zh) | 2001-04-28 | 2001-10-19 | 氨基酸碘络合物 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB018116701A Expired - Lifetime CN1207271C (zh) | 2001-04-28 | 2001-10-19 | 氨基酸碘络合物 |
Country Status (3)
Country | Link |
---|---|
US (1) | US7195772B2 (zh) |
CN (2) | CN1162399C (zh) |
WO (1) | WO2002088068A1 (zh) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9920351D0 (en) * | 1999-08-28 | 1999-11-03 | Strachen John S | Sparse constructive node stimulation of cell surface molecular resonance in vivo |
CN1480134A (zh) * | 2003-07-18 | 2004-03-10 | 曾雄飞 | 氨基酸碘组合物及其制备方法和应用 |
CN101967203B (zh) * | 2010-09-21 | 2012-05-30 | 农业部规划设计研究院 | 寡聚酸碘及其制备方法与应用 |
ES2476240T3 (es) * | 2010-12-30 | 2018-03-06 | Aktsionernoye Obshchestvo "Nauchnyi Tsentr Protivoinfektsionnyh Preparatov" | Agente antibacteriano para el tratamiento de enfermedades infecciosas de origen bacteriano |
US9149057B2 (en) * | 2011-03-01 | 2015-10-06 | Zinpro Corporation | Enhanced bioavailable iodine molecules |
CN102715189A (zh) * | 2011-03-30 | 2012-10-10 | 天津博莱恩科技发展有限公司 | 一种含碘的动物养殖室环境杀菌消毒剂 |
CN105213431A (zh) * | 2015-11-07 | 2016-01-06 | 昆明赛诺制药有限公司 | 一种康复新碘络合物的制备方法 |
CN107098314B (zh) | 2017-05-27 | 2019-03-19 | 农业部规划设计研究院 | 一种原子态流体碘及其衍生的纳米碘及制备方法与用途 |
CN108143744A (zh) * | 2017-11-17 | 2018-06-12 | 浙江师范大学 | 一种用于两栖类动物人工冬眠的抗低温应激保护剂 |
CN108719360A (zh) * | 2018-07-23 | 2018-11-02 | 安徽华星化工有限公司 | 一种杀螟丹和阿维菌素复配农药 |
CN109718247A (zh) * | 2019-01-23 | 2019-05-07 | 山东菏泽三仪生物工程有限公司 | 一种蛋氨酸碘溶液及其配置方法 |
JPWO2021215325A1 (zh) * | 2020-04-23 | 2021-10-28 | ||
CN111825776A (zh) * | 2020-06-10 | 2020-10-27 | 青岛海大生物集团有限公司 | 一种卤化海藻多糖的制备工艺及应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2517651A (en) * | 1944-10-16 | 1950-08-08 | Burnham Soluble Iodine Company | Treatment of waters for human consumption and iodine-diglycine hydriodide composition useful in such treatment |
JPH10203916A (ja) * | 1997-01-20 | 1998-08-04 | Mitsui Chem Inc | 固形ヨードホール組成物 |
-
2001
- 2001-04-28 CN CNB011146664A patent/CN1162399C/zh not_active Expired - Lifetime
- 2001-10-19 WO PCT/CN2001/001490 patent/WO2002088068A1/zh active Application Filing
- 2001-10-19 CN CNB018116701A patent/CN1207271C/zh not_active Expired - Lifetime
- 2001-10-19 US US10/312,521 patent/US7195772B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CN1318539A (zh) | 2001-10-24 |
CN1438990A (zh) | 2003-08-27 |
US7195772B2 (en) | 2007-03-27 |
WO2002088068A1 (fr) | 2002-11-07 |
CN1207271C (zh) | 2005-06-22 |
US20030171598A1 (en) | 2003-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1162399C (zh) | 氨基酸碘络合物 | |
US7060302B1 (en) | Metal-containing compositions, preparations and uses | |
DE69220397T2 (de) | Antimikrobielles Peptid und antimikrobieller Wirkstoff | |
EP1413303B1 (en) | Swine growth promoters and method of promoting swine growth | |
CN1907500A (zh) | 二氧化氯消毒剂 | |
Ivanovska et al. | Influence of cinnamic acid on lymphocyte proliferation, cytokine release and Klebsiella infection in mice | |
Ranasinghe et al. | Nutritional value and potential applications of jellyfish | |
WO2005007153A1 (fr) | Composition de complexe d'acide amine/iode et procedes de preparation et d'application | |
EP1519951A2 (fr) | Peptides lineaires cationiques ayant des proprietes antibacteriennes et/ou antifongiques | |
KR100454228B1 (ko) | 양식어류용 사료첨가제 | |
CN103936845B (zh) | 一种源于中华鳖的抗微生物肽及其基因、制备方法和应用 | |
JPH09301807A (ja) | 水生動物の寄生生物性疾患の予防および治療剤 | |
JP2005058106A (ja) | 食用組成物 | |
RU2102064C1 (ru) | Ветеринарный препарат для профилактики и лечения болезней вирусной и бактериальной природы | |
RU2218167C2 (ru) | Способ получения композиционного средства - мази "свф" | |
CN110960541B (zh) | 一种用于南美白对虾的药物组合物 | |
JP2003040783A (ja) | 医薬品や健康食品としてのタングステン酸塩やモリブデン酸塩と霊芝胞子添加物 | |
RU2230523C2 (ru) | Способ повышения продуктивности и неспецифической резистентности телят | |
JPH05148297A (ja) | 抗菌性ペプチドおよび抗菌剤 | |
RU2187314C1 (ru) | Способ лечения желудочно-кишечных заболеваний рыб | |
KR20010103486A (ko) | 스쿠치카충 감염증의 치료제 | |
JP3819445B2 (ja) | 水生動物の寄生生物性疾患予防および治療剤 | |
RU2067445C1 (ru) | Препарат "полифар" для лечения желудочно-кишечных болезней новорожденных телят | |
RU2281768C2 (ru) | Лечебный корм для рыб | |
RU2195938C1 (ru) | Способ получения регидратационного средства "регидратон свф" |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20040818 |